Loading
Our Products
A comprehensive range of pharmaceutical ingredients.
Sourced from trusted global manufacturers — API's, excipients, nutraceutical ingredients, formulations, and cosmetics raw materials.
Formulations
56Abiraterone Tablets
FormulationsFinished oncology tablets formulation. Available in 250 mg / 500 mg (2x14 Blister).
Oncology / Anticancer250 mg / 500 mg (2x14 Blister)TabletsPICSWHO-cGMP
Anastrozole Tablets
FormulationsFinished oncology tablets formulation. Available in 1 mg (30/120 in HDPE).
Oncology / Anticancer1 mg (30/120 in HDPE)TabletsPICSWHO-cGMP
Aprepitant Capsules
FormulationsFinished oncology capsules formulation. Available in 125 mg / 80 mg (Tri-blister Kit).
Oncology / Anticancer125 mg / 80 mg (Tri-blister Kit)CapsulesPICSWHO-cGMP
Azathioprine Tablets
FormulationsFinished oncology tablets formulation. Available in 50 mg (10x10 Blister).
Oncology / Anticancer50 mg (10x10 Blister)TabletsPICSWHO-cGMP
Bicalutamide Tablets
FormulationsFinished oncology tablets formulation. Available in 50 mg (30 in HDPE).
Oncology / Anticancer50 mg (30 in HDPE)TabletsPICSWHO-cGMP
Bleomycin for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 15 Units (Vial).
Oncology / Anticancer15 Units (Vial)Lyophilised InjectionPICSWHO-cGMP
Bortezomib for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 3.5 mg (Vial).
Oncology / Anticancer3.5 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Carboplatin Injection
FormulationsFinished oncology injection formulation. Available in 150 mg / 450 mg (Vial).
Oncology / Anticancer150 mg / 450 mg (Vial)InjectionPICSWHO-cGMP
Carfilzomib for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 60 mg (Vial).
Oncology / Anticancer60 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Chlorambucil Tablets
FormulationsFinished oncology tablets formulation. Available in 2 mg (25 in HDPE).
Oncology / Anticancer2 mg (25 in HDPE)TabletsPICSWHO-cGMP
Cisplatin Injection
FormulationsFinished oncology injection formulation. Available in 10 mg / 50 mg (Vial).
Oncology / Anticancer10 mg / 50 mg (Vial)InjectionPICSWHO-cGMP
Cyclophosphamide Tablets
FormulationsFinished oncology tablets formulation. Available in 50 mg (1x10 Blister).
Oncology / Anticancer50 mg (1x10 Blister)TabletsPICSWHO-cGMP
Cytarabine Injection
FormulationsFinished oncology injection formulation. Available in 100 mg / 500 mg / 1000 mg / 2000 mg (Vial).
Oncology / Anticancer100 mg / 500 mg / 1000 mg / 2000 mg (Vial)InjectionPICSWHO-cGMP
Dacarbazine for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 200 mg (Vial).
Oncology / Anticancer200 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Dasatinib Tablets
FormulationsFinished oncology tablets formulation. Available in 20 mg / 50 mg / 70 mg / 80 mg / 100 mg / 140 mg (60 in HDPE).
Oncology / Anticancer20/50/70/80/100/140 mg (60 in HDPE)TabletsPICSWHO-cGMP
Daunorubicin for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 20 mg (Vial).
Oncology / Anticancer20 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Docetaxel Injection
FormulationsFinished oncology injection formulation. Available in 20 mg / 80 mg / 120 mg (Vial).
Oncology / Anticancer20 mg / 80 mg / 120 mg (Vial)InjectionPICSWHO-cGMP
Doxorubicin for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 10 mg / 50 mg (Vial).
Oncology / Anticancer10 mg / 50 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Doxorubicin Hydrochloride Injection
FormulationsFinished oncology injection formulation. Available in 10 mg / 50 mg (Vial).
Oncology / Anticancer10 mg / 50 mg (Vial)InjectionPICSWHO-cGMP
Enzalutamide Capsules
FormulationsFinished oncology capsules formulation. Available in 40 mg (2x14 Blister).
Oncology / Anticancer40 mg (2x14 Blister)CapsulesPICSWHO-cGMP
Epirubicin Hydrochloride for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 10 mg / 50 mg (Vial).
Oncology / Anticancer10 mg / 50 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Erlotinib Tablets
FormulationsFinished oncology tablets formulation. Available in 25 mg / 100 mg / 150 mg (10 in HDPE).
Oncology / Anticancer25 mg / 100 mg / 150 mg (10 in HDPE)TabletsPICSWHO-cGMP
Etoposide Injection
FormulationsFinished oncology injection formulation. Available in 100 mg (Vial).
Oncology / Anticancer100 mg (Vial)InjectionPICSWHO-cGMP
Everolimus Tablets
FormulationsFinished oncology tablets formulation. Available in 5 mg / 10 mg (30 in HDPE).
Oncology / Anticancer5 mg / 10 mg (30 in HDPE)TabletsPICSWHO-cGMP
Exemestane Tablets
FormulationsFinished oncology tablets formulation. Available in 25 mg (1x10 Blister).
Oncology / Anticancer25 mg (1x10 Blister)TabletsPICSWHO-cGMP
Fluorouracil Injection
FormulationsFinished oncology injection formulation. Available in 250 mg / 500 mg / 1 gm (Vial).
Oncology / Anticancer250 mg / 500 mg / 1 gm (Vial)InjectionPICSWHO-cGMP
Flutamide Tablets
FormulationsFinished oncology tablets formulation. Available in 250 mg (30 in HDPE).
Oncology / Anticancer250 mg (30 in HDPE)TabletsPICSWHO-cGMP
Fulvestrant Injection
FormulationsFinished oncology injection formulation. Available in 250 mg (Vial).
Oncology / Anticancer250 mg (Vial)InjectionPICSWHO-cGMP
Gefitinib Tablets
FormulationsFinished oncology tablets formulation. Available in 250 mg (3x10 Blister).
Oncology / Anticancer250 mg (3x10 Blister)TabletsPICSWHO-cGMP
Gemcitabine for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 200 mg / 1000 mg (Vial).
Oncology / Anticancer200 mg / 1000 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Hydroxyurea Capsules
FormulationsFinished oncology capsules formulation. Available in 500 mg (10x10 Blister).
Oncology / Anticancer500 mg (10x10 Blister)CapsulesPICSWHO-cGMP
Ifosfamide for Injection USP
FormulationsFinished oncology lyophilised injection formulation. Available in 1000 mg (Vial).
Oncology / Anticancer1000 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Imatinib Tablets
FormulationsFinished oncology tablets formulation. Available in 100 mg / 400 mg (30 in HDPE).
Oncology / Anticancer100 mg / 400 mg (30 in HDPE)TabletsPICSWHO-cGMP
Irinotecan Hydrochloride Injection
FormulationsFinished oncology injection formulation. Available in 40 mg / 100 mg (Vial).
Oncology / Anticancer40 mg / 100 mg (Vial)InjectionPICSWHO-cGMP
L-Asparaginase for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 10000 IU (Vial).
Oncology / Anticancer10000 IU (Vial)Lyophilised InjectionPICSWHO-cGMP
Lapatinib Tablets
FormulationsFinished oncology tablets formulation. Available in 250 mg (25 in HDPE).
Oncology / Anticancer250 mg (25 in HDPE)TabletsPICSWHO-cGMP
Lenalidomide Capsules
FormulationsFinished oncology capsules formulation. Available in 5 mg / 10 mg / 15 mg / 20 mg / 25 mg (30 in HDPE).
Oncology / Anticancer5/10/15/20/25 mg (30 in HDPE)CapsulesPICSWHO-cGMP
Lenvatinib Capsules
FormulationsFinished oncology capsules formulation. Available in 4 mg / 10 mg (30 in HDPE).
Oncology / Anticancer4 mg / 10 mg (30 in HDPE)CapsulesPICSWHO-cGMP
Letrozole Tablets
FormulationsFinished oncology tablets formulation. Available in 2.5 mg (30 in HDPE).
Oncology / Anticancer2.5 mg (30 in HDPE)TabletsPICSWHO-cGMP
Leucovorin Calcium Injection
FormulationsFinished oncology injection formulation. Available in 10 mg / 30 mg / 50 mg (Vial).
Oncology / Anticancer10 mg / 30 mg / 50 mg (Vial)InjectionPICSWHO-cGMP
Melphalan Tablets
FormulationsFinished oncology tablets formulation. Available in 2 mg (30 in HDPE).
Oncology / Anticancer2 mg (30 in HDPE)TabletsPICSWHO-cGMP
Mercaptopurine Tablets
FormulationsFinished oncology tablets formulation. Available in 50 mg (30 in HDPE).
Oncology / Anticancer50 mg (30 in HDPE)TabletsPICSWHO-cGMP
Methotrexate Injection
FormulationsFinished oncology injection formulation. Available in 50 mg / 500 mg / 1000 mg (Vial).
Oncology / Anticancer50 mg / 500 mg / 1000 mg (Vial)InjectionPICSWHO-cGMP
Methotrexate Tablets
FormulationsFinished oncology tablets formulation. Available in 2.5 mg / 5 mg / 7.5 mg / 10 mg / 15 mg / 20 mg / 25 mg (10x10 Blister).
Oncology / Anticancer2.5/5/7.5/10/15/20/25 mg (10x10 Blister)TabletsPICSWHO-cGMP
Mitomycin for Injection
FormulationsFinished oncology lyophilised injection formulation. Available in 20 mg (Vial).
Oncology / Anticancer20 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Nilotinib Capsules
FormulationsFinished oncology capsules formulation. Available in 150 mg / 200 mg (1x14 Blister).
Oncology / Anticancer150 mg / 200 mg (1x14 Blister)CapsulesPICSWHO-cGMP
Oxaliplatin Injection
FormulationsFinished oncology injection formulation. Available in 50 mg / 100 mg (Vial).
Oncology / Anticancer50 mg / 100 mg (Vial)InjectionPICSWHO-cGMP
Paclitaxel Injection
FormulationsFinished oncology injection formulation. Available in 30 mg / 100 mg / 260 mg / 300 mg (Vial).
Oncology / Anticancer30 mg / 100 mg / 260 mg / 300 mg (Vial)InjectionPICSWHO-cGMP
Pazopanib Tablets
FormulationsFinished oncology tablets formulation. Available in 200 mg / 400 mg (30 in HDPE).
Oncology / Anticancer200 mg / 400 mg (30 in HDPE)TabletsPICSWHO-cGMP
PEG L-Asparaginase Injection
FormulationsFinished oncology injection formulation. Available in 3750 IU / 5 ml (Vial).
Oncology / Anticancer3750 IU / 5 ml (Vial)InjectionPICSWHO-cGMP
Pomalidomide Capsules
FormulationsFinished oncology capsules formulation. Available in 1 mg / 2 mg / 3 mg / 4 mg (21 in HDPE).
Oncology / Anticancer1/2/3/4 mg (21 in HDPE)CapsulesPICSWHO-cGMP
Sorafenib Tablets
FormulationsFinished oncology tablets formulation. Available in 200 mg (30 in HDPE).
Oncology / Anticancer200 mg (30 in HDPE)TabletsPICSWHO-cGMP
Sunitinib Capsules
FormulationsFinished oncology capsules formulation. Available in 12.5 mg / 25 mg / 37.5 mg / 50 mg (28 in HDPE).
Oncology / Anticancer12.5/25/37.5/50 mg (28 in HDPE)CapsulesPICSWHO-cGMP
Temozolomide Capsules
FormulationsFinished oncology capsules formulation. Available in 20 mg / 100 mg / 140 mg / 180 mg / 250 mg (5 in HDPE).
Oncology / Anticancer20/100/140/180/250 mg (5 in HDPE)CapsulesPICSWHO-cGMP
Zoledronic Acid for Injection (Lyophilised)
FormulationsFinished oncology lyophilised injection formulation. Available in 4 mg (Vial).
Oncology / Anticancer4 mg (Vial)Lyophilised InjectionPICSWHO-cGMP
Zoledronic Acid Injection
FormulationsFinished oncology injection formulation. Available in 4 mg / 5 ml (Vial).
Oncology / Anticancer4 mg / 5 ml (Vial)InjectionPICSWHO-cGMP
Can't find what you're looking for?
Our team can help you source the right product for your needs.